abstract |
The present invention relates to triazolopyridine compounds of formula (I), wherein R 1 , R 2 , R 3 and R 4 are as defined in the description and claims, and physiologically acceptable salts thereof. These compounds inhibit PDEIOA and can be used as medicines. |